about
Toward understanding and exploiting tumor heterogeneityAn ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice.Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes.B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progressionPotential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq.Probing lymphocyte biology by genomic-scale gene expression analysis.Integrated digital error suppression for improved detection of circulating tumor DNAFACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution.Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alphaTransient expression of Bcl6 is sufficient for oncogenic function and induction of mature B-cell lymphoma.Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentationLarge-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human AgingNoninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.Organocatalytic removal of formaldehyde adducts from RNA and DNA basesPredicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.Robust enumeration of cell subsets from tissue expression profilesHigh PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.The prognostic landscape of genes and infiltrating immune cells across human cancersCirculating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience.Tumor antigen discovery through translation of the cancer genome.Common progenitor cells in mature B-cell malignancies: implications for therapy.High-throughput sequencing for noninvasive disease detection in hematologic malignancies.Data normalization considerations for digital tumor dissection.High-throughput genomic profiling of tumor-infiltrating leukocytes.Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.Diagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan-virus microarrayRole of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.Hit-and-run lymphomagenesis by the Bcl6 oncogeneMixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria.AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.
P50
Q28603034-9F9C7080-BB47-4E7C-A293-9354F23352AFQ33590850-82EDFDAB-AAAD-4910-946C-989EB276E126Q33671971-45B1DD31-A632-4625-AB9B-ED9FACAA48F5Q33851726-79983899-553D-4A2B-A948-CD6785C81183Q33873844-60EAAF69-21DF-4354-B235-91C43598D822Q33936389-0B5FE653-A5B4-4C1C-98FF-12C0A262935BQ34059352-2A68EC2F-387C-4223-8A5E-6A61A11912C6Q34467274-C21055F9-EC3E-4949-8321-F53A0E0DC792Q34483994-8800CA77-52CA-4840-8B7B-53A22AA37D9BQ34520008-F90EBCEB-CD02-40D9-B1E8-0C6B534FBFF1Q34974672-A79AD340-6E4C-4237-A5F0-B328F583C6E7Q34975323-CF0651DC-B52C-4818-BB1D-69325434D690Q35063947-919F7325-58F6-4168-AA46-5B7800DD4FB2Q35189915-D96620F0-936B-4644-B02D-196CBF1362C7Q35703423-A4E8B13C-0943-408E-88CE-31F6197341E4Q35723986-6346F1A4-2580-481C-8A71-E9FB478A3A9CQ35751384-109C8702-E58A-4108-B21C-3600E2AD0227Q36073981-49A6D332-DAAD-409C-B721-EBB05854690EQ36131712-1B3E055E-1CA0-4981-9D09-ABF4B031C2A6Q36204132-2A9D8737-4396-4C49-94D2-65DD75222244Q36539395-C567136E-6343-493D-860A-DF70B66EEDADQ36628291-58D19F6A-81F7-4FD9-89DD-8BAD8D97591FQ36857285-8D6ACB52-0641-4E90-AC0A-99673E60843FQ37000646-F940B36E-6CFF-4090-BED0-DB30AA8AC7A4Q37305045-6D51B7B9-3E44-494F-9616-7F68ECCCAAC9Q37792960-BBB24F68-E071-4872-999B-A5E12FFB4B60Q38203472-85A26B0A-571D-4D41-A8F8-3C291461413AQ38210394-B999FAE4-779A-4FC8-A193-82D5D1B1342EQ38672646-A686926B-8A89-4193-AD7A-17115FB28128Q38692493-3C0E50C2-34A1-4AD5-9793-DAA3A67A281AQ38884388-ABC62D91-CAF8-4B85-AAB9-32FFC2EE083CQ40536285-0E8A7456-64A1-4612-9A20-7D796D89F720Q40629175-7AC5527F-240F-4B94-9181-27F758D9BCEFQ42432298-2032A5F8-B0FD-432A-9936-E9352A4A6A5CQ42499478-681D77E2-0517-4DD9-B975-F5A070BA7182Q42503470-A076197D-6349-4A62-8E45-B5340C7231FCQ42750073-3EAC2E3C-324F-4866-B710-37578347A7F5Q44068364-1BA49321-B5CF-4372-81E3-72AF3E768D87Q45073113-0B24F6A0-1EFB-49CB-A99B-50C5F370E85AQ45182737-600BBD6B-4B99-4DFE-848A-F82D4592F23D
P50
description
researcher
@en
wetenschapper
@nl
name
A Alizadeh
@en
A Alizadeh
@nl
type
label
A Alizadeh
@en
A Alizadeh
@nl
prefLabel
A Alizadeh
@en
A Alizadeh
@nl
P106
P31
P496
0000-0002-5153-5625